A detailed history of Sei Investments CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 189,837 shares of IONS stock, worth $6.85 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
189,837
Previous 132,311 43.48%
Holding current value
$6.85 Million
Previous $6.31 Million 20.6%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $2.3 Million - $2.98 Million
57,526 Added 43.48%
189,837 $7.6 Million
Q2 2024

Aug 13, 2024

BUY
$36.45 - $47.7 $1.91 Million - $2.5 Million
52,424 Added 65.62%
132,311 $6.31 Million
Q1 2024

May 07, 2024

BUY
$42.03 - $53.55 $408,279 - $520,184
9,714 Added 13.84%
79,887 $3.46 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $236,996 - $282,003
5,462 Added 8.44%
70,173 $3.55 Million
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $1.9 Million - $2.33 Million
49,401 Added 322.67%
64,711 $2.94 Million
Q2 2023

Aug 11, 2023

SELL
$34.73 - $43.33 $1.06 Million - $1.33 Million
-30,614 Reduced 66.66%
15,310 $628,000
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $570 - $700
-17 Reduced 0.04%
45,924 $1.64 Million
Q4 2022

Feb 10, 2023

BUY
$37.12 - $46.52 $995,261 - $1.25 Million
26,812 Added 140.16%
45,941 $1.74 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $310,699 - $413,755
8,503 Added 80.02%
19,129 $845,000
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $12,430 - $16,856
-392 Reduced 3.56%
10,626 $392,000
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $5,258 - $6,519
-176 Reduced 1.57%
11,018 $407,000
Q4 2021

Feb 14, 2022

SELL
$25.61 - $35.1 $70,760 - $96,981
-2,763 Reduced 19.8%
11,194 $339,000
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $3,186 - $3,852
-95 Reduced 0.68%
13,957 $401,000
Q2 2021

Aug 06, 2021

SELL
$34.54 - $47.25 $463,181 - $633,622
-13,410 Reduced 48.83%
14,052 $492,000
Q1 2021

May 12, 2021

BUY
$42.51 - $63.78 $34,475 - $51,725
811 Added 3.04%
27,462 $1.38 Million
Q4 2020

Feb 08, 2021

SELL
$45.3 - $60.27 $2.65 Million - $3.52 Million
-58,480 Reduced 68.69%
26,651 $1.46 Million
Q3 2020

Dec 04, 2020

SELL
$47.45 - $62.95 $12,858 - $17,059
-271 Reduced 0.32%
85,131 $4.01 Million
Q3 2020

Nov 06, 2020

SELL
$47.45 - $62.95 $410,395 - $544,454
-8,649 Reduced 9.2%
85,402 $4.03 Million
Q2 2020

Aug 17, 2020

SELL
$46.85 - $61.05 $347,627 - $452,991
-7,420 Reduced 7.31%
94,051 $5.53 Million
Q2 2020

Aug 11, 2020

BUY
$46.85 - $61.05 $514,787 - $670,817
10,988 Added 12.14%
101,471 $6.11 Million
Q1 2020

May 14, 2020

SELL
$41.6 - $63.4 $341,702 - $520,767
-8,214 Reduced 8.32%
90,483 $4.28 Million
Q4 2019

Feb 06, 2020

BUY
$53.85 - $65.27 $1.43 Million - $1.73 Million
26,555 Added 36.81%
98,697 $5.96 Million
Q3 2019

Nov 12, 2019

BUY
$59.06 - $72.15 $183,145 - $223,737
3,101 Added 4.49%
72,142 $4.32 Million
Q2 2019

Aug 14, 2019

BUY
$62.09 - $86.14 $111,265 - $154,362
1,792 Added 2.66%
69,041 $4.44 Million
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $675,894 - $1.04 Million
12,772 Added 23.44%
67,249 $5.46 Million
Q3 2018

Nov 08, 2018

SELL
$42.88 - $53.7 $1.92 Million - $2.4 Million
-44,728 Reduced 45.09%
54,477 $2.81 Million
Q2 2018

Aug 03, 2018

BUY
$40.53 - $50.7 $955,373 - $1.2 Million
23,572 Added 31.17%
99,205 $4.13 Million
Q1 2018

May 11, 2018

BUY
$44.08 - $55.05 $848,011 - $1.06 Million
19,238 Added 34.11%
75,633 $3.33 Million
Q4 2017

Feb 08, 2018

BUY
$50.3 - $64.39 $27,463 - $35,156
546 Added 0.98%
56,395 $2.84 Million
Q3 2017

Nov 06, 2017

BUY
$45.56 - $59.57 $2.54 Million - $3.33 Million
55,849
55,849 $2.83 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.12B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.